NF-κB: linking inflammation and immunity to cancer development and progression (original) (raw)

• Balkwill, F. & Mantovani, A. Inflammation and cancer: back to Virchow? Lancet 357, 539–545 (2001).
  Article CAS PubMed Google Scholar
• Kuper, H., Adami, H. O. & Trichopoulos, D. Infections as a major preventable cause of human cancer. J. Intern. Med. 248, 171–183 (2000).
  Article CAS PubMed Google Scholar
• Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860–867 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Roder, D. M. The epidemiology of gastric cancer. Gastric Cancer 5 (Suppl. 1), 5–11 (2002).
  Article PubMed Google Scholar
• Warzocha, K. et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91, 3574–3581 (1998).
  CAS PubMed Google Scholar
• El-Omar, E. M. et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404, 398–402 (2000).
  Article CAS PubMed Google Scholar
• Sun, J. et al. Sequence variants in Toll-like receptor gene cluster (TLR6_–_TLR1_–_TLR10) and prostate cancer risk. J. Natl Cancer Inst. 97, 525–532 (2005).
  Article CAS PubMed Google Scholar
• Bharti, A. C. & Aggarwal, B. B. Chemopreventive agents induce suppression of nuclear factor-κB leading to chemosensitization. Ann. NY Acad. Sci. 973, 392–395 (2002).
  Article CAS PubMed Google Scholar
• Wang, W. H. et al. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J. Natl Cancer Inst. 95, 1784–1791 (2003).
  Article CAS PubMed Google Scholar
• Garber, K. Aspirin for cancer chemoprevention: still a headache? J. Natl Cancer Inst. 96, 252–253 (2004).
  Article PubMed Google Scholar
• Ness, R. B. & Cottreau, C. Possible role of ovarian epithelial inflammation in ovarian cancer. J. Natl Cancer Inst. 91, 1459–1467 (1999).
  Article CAS PubMed Google Scholar
• Chang, E. T. et al. Aspirin and the risk of Hodgkin's lymphoma in a population-based case–control study. J. Natl Cancer Inst. 96, 305–315 (2004).
  Article CAS PubMed Google Scholar
• Cerhan, J. R. et al. Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma. Int. J. Cancer 106, 784–788 (2003).
  Article CAS PubMed Google Scholar
• Schernhammer, E. S. et al. A prospective study of aspirin use and the risk of pancreatic cancer in women. J. Natl Cancer Inst. 96, 22–28 (2004).
  Article CAS PubMed Google Scholar
• Burnet, F. M. The concept of immunological surveillance. Prog. Exp. Tumor Res. 13, 1–17 (1970).
  Article CAS PubMed Google Scholar
• Dunn, G. P., Old, L. J. & Schreiber, R. D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21, 137–148 (2004).
  Article CAS PubMed Google Scholar
• Pardoll, D. Does the immune system see tumours as foreign or self? Annu. Rev. Immunol. 21, 807–839 (2003). References 16 and 17 are excellent reviews of the theory of immunoediting.
  Article CAS PubMed Google Scholar
• Philip, M., Rowley, D. A. & Schreiber, H. Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 14, 433–439 (2004).
  Article CAS PubMed Google Scholar
• Luo, J. L., Maeda, S., Hsu, L. C., Yagita, H. & Karin, M. Inhibition of NF-κB in cancer cells converts inflammation-induced tumor growth mediated by TNFα to TRAIL-mediated tumor regression. Cancer Cell 6, 297–305 (2004).
  Article CAS PubMed Google Scholar
• Chisari, F. V. Hepatitis B virus transgenic mice: insights into the virus and the disease. Hepatology 22, 1316–1325 (1995).
  CAS PubMed Google Scholar
• de Visser, K. E., Korets, L. V. & Coussens, L. M. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 7, 411–423 (2005).
  Article CAS PubMed Google Scholar
• Karin, M., Cao, Y., Greten, F. R. & Li, Z. W. NF-κB in cancer: from innocent bystander to major culprit. Nature Rev. Cancer 2, 301–310 (2002).
  Article CAS Google Scholar
• Greten, F. R. et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285–296 (2004).
  Article CAS PubMed Google Scholar
• Pikarsky, E. et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 431, 461–466 (2004). References 23 and 24 were the first to describe IKK-β-dependent NF-κB activation as the molecular link between inflammation and cancer.
  Article CAS PubMed Google Scholar
• Bonizzi, G. & Karin, M. The two NF-κB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280–288 (2004).
  Article CAS PubMed Google Scholar
• Hayden, M. S. & Ghosh, S. Signaling to NF-κB. Genes Dev. 18, 2195–2224 (2004).
  Article CAS PubMed Google Scholar
• Ghosh, S. & Karin, M. Missing pieces in the NF-κB puzzle. Cell 109, S81–S96 (2002).
  Article CAS PubMed Google Scholar
• Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V. & Karin, M. IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation. Nature 434, 1138–1143 (2005).
  Article CAS PubMed Google Scholar
• Maeda, S., Kamata, H., Luo, J. L., Leffert, H. & Karin, M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121, 977–990 (2005). This paper describes the role of IKK-β-dependent NF-κB activation in chemically induced HCC, and it was the first to show that compensatory proliferation that depends on production of pro-inflammatory cytokines is important in carcinogenesis.
  Article CAS PubMed Google Scholar
• Mauad, T. H. et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 145, 1237–1245 (1994).
  CAS PubMed PubMed Central Google Scholar
• Becker, C. et al. TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 _trans_-signaling. Immunity 21, 491–501 (2004). This paper describes the importance of T-cell-mediated, IL-6 signalling in the development of CAC.
  Article CAS PubMed Google Scholar
• Li, Z.-W. et al. The IKKβ subunit of IκB kinase (IKK) is essential for NF-κB activation and prevention of apoptosis. J. Exp. Med. 189, 1839–1845 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Kamata, H. et al. Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649–661 (2005).
  Article CAS PubMed Google Scholar
• Vakkila, J. & Lotze, M. T. Inflammation and necrosis promote tumour growth. Nature Rev. Immunol. 4, 641–648 (2004).
  Article CAS Google Scholar
• Fausto, N. Liver regeneration. J. Hepatol. 32, 19–31 (2000).
  Article CAS PubMed Google Scholar
• Zeh, H. J. & Lotze, M. T. Addicted to death: invasive cancer and the immune response to unscheduled cell death. J. Immunother. 28, 1–9 (2005).
  Article PubMed Google Scholar
• Conejo-Garcia, J. R. et al. Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A. Nature Med. 10, 950–958 (2004).
  Article CAS PubMed Google Scholar
• Moore, R. J. et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nature Med. 5, 828–831 (1999).
  Article CAS PubMed Google Scholar
• Arnott, C. H. et al. Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development. Oncogene 23, 1902–1910 (2004).
  Article CAS PubMed Google Scholar
• Szabowski, A. et al. c-Jun and JunB antagonistically control cytokine-regulated mesenchymal–epidermal interaction in skin. Cell 103, 745–755 (2000).
  Article CAS PubMed Google Scholar
• Arnott, C. H. et al. Tumour necrosis factor-α mediates tumour promotion via a PKC α- and AP-1-dependent pathway. Oncogene 21, 4728–4738 (2002).
  Article CAS PubMed Google Scholar
• van Hogerlinden, M., Rozell, B. L., Ahrlund-Richter, L. & Toftgard, R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-κB signaling. Cancer Res. 59, 3299–3303 (1999).
  CAS PubMed Google Scholar
• van Hogerlinden, M., Auer, G. & Toftgard, R. Inhibition of Rel/nuclear factor-κB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development. Oncogene 21, 4969–4977 (2002).
  Article CAS PubMed Google Scholar
• Seitz, C. S., Lin, Q., Deng, H. & Khavari, P. A. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl Acad. Sci. USA 95, 2307–2312 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Dajee, M. et al. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421, 639–643 (2003).
  Article CAS PubMed Google Scholar
• Lind, M. H. et al. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition. Proc. Natl Acad. Sci. USA 101, 4972–4977 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Zhang, J. Y., Green, C. L., Tao, S. & Khavari, P. A. NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 18, 17–22 (2004). References 46 and 47 describe TNF as a tumour promoter and show that the balance between JNK and NF-κB activation is essential for the development of skin cancer.
  Article CAS PubMed PubMed Central Google Scholar
• Korner, H. et al. Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype. J. Exp. Med. 191, 89–96 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Balkwill, F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13, 135–141 (2002).
  Article CAS PubMed Google Scholar
• Galban, S. et al. von Hippel–Lindau protein-mediated repression of tumor necrosis factor α translation revealed through use of cDNA arrays. Mol. Cell. Biol. 23, 2316–2328 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Nauts, H. C., Fowler, G. A. & Bogatko, F. H. A review of the influence of bacterial infection and of bacterial products (Coley's toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley's mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med. Scand. Suppl. 144, 1–103 (1953).
  Google Scholar
• Duncan, L. M., Richards, L. A. & Mihm, M. C. Jr. Increased mast cell density in invasive melanoma. J. Cutan. Pathol. 25, 11–15 (1998).
  Article CAS PubMed Google Scholar
• Pollard, J. W. Tumour-educated macrophages promote tumour progression and metastasis. Nature Rev. Cancer 4, 71–78 (2004).
  Article CAS Google Scholar
• Menetrier-Caux, C. et al. Inhibition of the differentiation of dendritic cells from CD34+ progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92, 4778–4791 (1998).
  CAS PubMed Google Scholar
• Curiel, T. J. et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Med. 10, 942–949 (2004).
  Article CAS PubMed Google Scholar
• Iellem, A. et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 194, 847–853 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Erdman, S. E. et al. CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in Apc Min/+ mice. Cancer Res. 65, 3998–4004 (2005).
  Article CAS PubMed Google Scholar
• Balkwill, F., Charles, K. A. & Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 7, 211–217 (2005).
  Article CAS PubMed Google Scholar
• Fadok, V. A., Bratton, D. L., Guthrie, L. & Henson, P. M. Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases. J. Immunol. 166, 6847–6854 (2001).
  Article CAS PubMed Google Scholar
• Engle, S. J. et al. Transforming growth factor β1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 59, 3379–3386 (1999).
  CAS PubMed Google Scholar
• Berg, D. J. et al. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses. J. Clin. Invest. 98, 1010–1020 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Goodman, J. E., Hofseth, L. J., Hussain, S. P. & Harris, C. C. Nitric oxide and p53 in cancer-prone chronic inflammation and oxyradical overload disease. Environ. Mol. Mutagen. 44, 3–9 (2004).
  Article CAS PubMed Google Scholar
• Schioppa, T. et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J. Exp. Med. 198, 1391–1402 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bando, H. & Toi, M. Tumor angiogenesis, macrophages, and cytokines. Adv. Exp. Med. Biol. 476, 267–284 (2000).
  Article CAS PubMed Google Scholar
• Leek, R. D. et al. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J. Pathol. 190, 430–436 (2000).
  Article CAS PubMed Google Scholar
• Barleon, B. et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336–3343 (1996).
  CAS PubMed Google Scholar
• Sparmann, A. & Bar-Sagi, D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6, 447–458 (2004).
  Article CAS PubMed Google Scholar
• Jung, Y. J., Isaacs, J. S., Lee, S., Trepel, J. & Neckers, L. IL-1β-mediated up-regulation of HIF-1α via an NF-κB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J. 17, 2115–2117 (2003).
  Article CAS PubMed Google Scholar
• Voronov, E. et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA 100, 2645–2650 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Weinreich, D. M. et al. Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice. Cancer Res. 63, 5957–5961 (2003).
  CAS PubMed Google Scholar
• Melcher, A. et al. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nature Med. 4, 581–587 (1998).
  Article CAS PubMed Google Scholar
• Houghton, J. et al. Gastric cancer originating from bone marrow-derived cells. Science 306, 1568–1571 (2004). This paper describes how bone-marrow-derived cells can differentiate into epithelial cancer cells, and it provides the first molecular evidence of a role for inflammation in tumour initiation.
  Article CAS PubMed Google Scholar
• Keates, S., Hitti, Y. S., Upton, M. & Kelly, C. P. Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 113, 1099–1109 (1997).
  Article CAS PubMed Google Scholar
• Barnes, P. J. & Karin, M. NF-κB — a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066–1071 (1997).
  Article CAS PubMed Google Scholar
• Radisky, D. C. et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436, 123–127 (2005). This paper provides a molecular mechanism by which protease-induced epithelial–mesenchymal transition can stimulate ROS production and thereby increase genomic instability.
  Article CAS PubMed PubMed Central Google Scholar
• Hudson, J. D. et al. A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med. 190, 1375–1382 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Shankaran, V. et al. IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 410, 1107–1111 (2001).
  Article CAS PubMed Google Scholar
• Girardi, M. et al. Regulation of cutaneous malignancy by γδ T cells. Science 294, 605–609 (2001).
  Article CAS PubMed Google Scholar
• Girardi, M. et al. The distinct contributions of murine T cell receptor (TCR)γδ+ and TCRαβ+ T cells to different stages of chemically induced skin cancer. J. Exp. Med. 198, 747–755 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Street, S. E., Cretney, E. & Smyth, M. J. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97, 192–197 (2001).
  Article CAS PubMed Google Scholar
• Kaplan, D. H. et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc. Natl Acad. Sci. USA 95, 7556–7561 (1998).
  CAS PubMed PubMed Central Google Scholar
• Interferon α versus chemotherapy for chronic myeloid leukemia: a metaanalysis of seven randomized trials: Chronic Myeloid Leukemia Trialists' Collaborative Group. J. Natl Cancer Inst. 89, 1616–1620 (1997).
• Schmidt, M. et al. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91, 22–29 (1998).
  CAS PubMed Google Scholar
• Takaoka, A. et al. Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516–523 (2003). This paper shows that type I IFNs can sensitize cells to p53-mediated apoptosis, implying that type II IFNs might not be the only IFNs involved in tumour development.
  Article CAS PubMed Google Scholar
• Smyth, M. J. et al. Nature's TRAIL — on a path to cancer immunotherapy. Immunity 18, 1–6 (2003).
  Article CAS PubMed Google Scholar
• Dranoff, G. Cytokines in cancer pathogenesis and cancer therapy. Nature Rev. Cancer 4, 11–22 (2004).
  Article CAS Google Scholar
• Koehne, C. H. & Dubois, R. N. COX-2 inhibition and colorectal cancer. Semin. Oncol. 31, 12–21 (2004).
  Article CAS PubMed Google Scholar
• Steinbach, G. et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342, 1946–1952 (2000).
  Article CAS PubMed Google Scholar
• Solomon, S. D. et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med. 352, 1071–1080 (2005).
  Article CAS PubMed Google Scholar
• Bresalier, R. S. et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N. Engl. J. Med. 352, 1092–1102 (2005).
  Article CAS PubMed Google Scholar
• Karin, M., Yamamoto, Y. & Wang, Q. M. The IKK NF-κB system: a treasure trove for drug development. Nature Rev. Drug Discov. 3, 17–26 (2004).
  Article CAS Google Scholar
• Li, Q. & Verma, I. M. NF-κB regulation in the immune system. Nature Rev. Immunol. 2, 725–734 (2002).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS PubMed Google Scholar